These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7562403)

  • 1. Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis.
    Nolen H; Fedorak RN; Friend DR
    J Pharm Sci; 1995 Jun; 84(6):677-81. PubMed ID: 7562403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery.
    Haeberlin B; Rubas W; Nolen HW; Friend DR
    Pharm Res; 1993 Nov; 10(11):1553-62. PubMed ID: 8290467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic rats.
    Nolen HW; Fedorak RN; Friend DR
    Biopharm Drug Dispos; 1997 Nov; 18(8):681-95. PubMed ID: 9373725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A budesonide prodrug accelerates treatment of colitis in rats.
    Cui N; Friend DR; Fedorak RN
    Gut; 1994 Oct; 35(10):1439-46. PubMed ID: 7959202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression.
    Fedorak RN; Haeberlin B; Empey LR; Cui N; Nolen H; Jewell LD; Friend DR
    Gastroenterology; 1995 Jun; 108(6):1688-99. PubMed ID: 7768373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menthol-beta-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndrome.
    Nolen HW; Friend DR
    Pharm Res; 1994 Dec; 11(12):1707-11. PubMed ID: 7899232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.
    Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F
    Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig.
    Tozer TN; Rigod J; McLeod AD; Gungon R; Hoag MK; Friend DR
    Pharm Res; 1991 Apr; 8(4):445-54. PubMed ID: 1871038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of site-specific delivery of dexamethasone-dextran prodrug in rat gastrointestinal tract].
    Zhou SY; Mei QB; Zhou J; Liu L; Li C; Zhao DH
    Yao Xue Xue Bao; 2001 May; 36(5):325-8. PubMed ID: 12584851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine.
    Kim I; Kong H; Lee Y; Hong S; Han J; Jung S; Jung Y; Kim YM
    Pharm Res; 2009 Feb; 26(2):415-21. PubMed ID: 18958401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro properties of dexamethasone 21-sulfate sodium as a colon-specific prodrug of dexamethasone.
    Kim IH; Kong HS; Choi BI; Kim YS; Kim HJ; Yang YW; Jung YJ; Kim YM
    Drug Dev Ind Pharm; 2006 Mar; 32(3):389-97. PubMed ID: 16556543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.
    McLeod AD; Friend DR; Tozer TN
    J Pharm Sci; 1994 Sep; 83(9):1284-8. PubMed ID: 7530303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis.
    Varshosaz J; Emami J; Ahmadi F; Tavakoli N; Minaiyan M; Fassihi A; Mahzouni P; Dorkoosh F
    J Drug Target; 2011 Feb; 19(2):140-53. PubMed ID: 20429772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel colon-specific steroid prodrug enhances sodium chloride absorption in rat colitis.
    Fedorak RN; Cui N; Friend DR; Madsen KL; Empey LR
    Am J Physiol; 1995 Aug; 269(2 Pt 1):G210-8. PubMed ID: 7653560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.
    Ahmadi F; Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
    Drug Deliv; 2011 Feb; 18(2):122-30. PubMed ID: 20954795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis.
    Löfberg R; Ostergaard Thomsen O; Langholz E; Schiöler R; Danielsson A; Suhr O; Graffner H; Påhlman L; Matzen P; Møller-Petersen JF
    Aliment Pharmacol Ther; 1994 Dec; 8(6):623-9. PubMed ID: 7696452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug glycosides: potential prodrugs for colon-specific drug delivery.
    Friend DR; Chang GW
    J Med Chem; 1985 Jan; 28(1):51-7. PubMed ID: 3965714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of budesonide enema in patients with distal ulcerative colitis or proctitis.
    Danielsson A; Edsbäcker S; Löfberg R; Nilsson A; Nyman-Pantelidis M; Olsson O; Suhr O; Willén R
    Aliment Pharmacol Ther; 1993 Aug; 7(4):401-7. PubMed ID: 8218754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and retrograde colonic spread of budesonide enemas in patients with distal ulcerative colitis.
    Nyman-Pantelidis M; Nilsson A; Wagner ZG; Borgå O
    Aliment Pharmacol Ther; 1994 Dec; 8(6):617-22. PubMed ID: 7696451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation.
    Tammara VK; Narurkar MM; Crider AM; Khan MA
    J Pharm Sci; 1994 May; 83(5):644-8. PubMed ID: 8071813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.